MD4277C1 - Utilizarea extractului din biomasa tulpinii cianobacteriei Spirulina platensis (Nordst) Getil CNMN-CB-02 pentru tratamentul pacienţilor cu hipoacuzie neurosenzorială - Google Patents
Utilizarea extractului din biomasa tulpinii cianobacteriei Spirulina platensis (Nordst) Getil CNMN-CB-02 pentru tratamentul pacienţilor cu hipoacuzie neurosenzorială Download PDFInfo
- Publication number
- MD4277C1 MD4277C1 MDA20130056A MD20130056A MD4277C1 MD 4277 C1 MD4277 C1 MD 4277C1 MD A20130056 A MDA20130056 A MD A20130056A MD 20130056 A MD20130056 A MD 20130056A MD 4277 C1 MD4277 C1 MD 4277C1
- Authority
- MD
- Moldova
- Prior art keywords
- treatment
- patients
- extract
- getil
- nordst
- Prior art date
Links
- 206010011891 Deafness neurosensory Diseases 0.000 title claims abstract description 11
- 208000009966 Sensorineural Hearing Loss Diseases 0.000 title claims abstract description 11
- 208000023573 sensorineural hearing loss disease Diseases 0.000 title claims abstract description 11
- 240000002900 Arthrospira platensis Species 0.000 title claims abstract description 5
- 239000002028 Biomass Substances 0.000 title claims abstract description 5
- 235000016425 Arthrospira platensis Nutrition 0.000 title claims description 4
- 241001464430 Cyanobacterium Species 0.000 title claims description 4
- 231100000879 sensorineural hearing loss Toxicity 0.000 claims abstract description 9
- 235000012054 meals Nutrition 0.000 claims abstract description 5
- 239000003814 drug Substances 0.000 abstract description 5
- 238000002360 preparation method Methods 0.000 description 13
- 230000003078 antioxidant effect Effects 0.000 description 10
- 239000002775 capsule Substances 0.000 description 7
- 238000012076 audiometry Methods 0.000 description 6
- 208000016354 hearing loss disease Diseases 0.000 description 6
- 239000003963 antioxidant agent Substances 0.000 description 5
- 235000006708 antioxidants Nutrition 0.000 description 5
- 208000009205 Tinnitus Diseases 0.000 description 4
- 238000000034 method Methods 0.000 description 4
- 238000001228 spectrum Methods 0.000 description 4
- 231100000886 tinnitus Toxicity 0.000 description 4
- 206010048865 Hypoacusis Diseases 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- 206010011878 Deafness Diseases 0.000 description 2
- 108010038807 Oligopeptides Proteins 0.000 description 2
- 102000015636 Oligopeptides Human genes 0.000 description 2
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 2
- 230000002490 cerebral effect Effects 0.000 description 2
- 230000001684 chronic effect Effects 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- RWSXRVCMGQZWBV-WDSKDSINSA-N glutathione Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O RWSXRVCMGQZWBV-WDSKDSINSA-N 0.000 description 2
- 231100000888 hearing loss Toxicity 0.000 description 2
- 230000010370 hearing loss Effects 0.000 description 2
- 239000002858 neurotransmitter agent Substances 0.000 description 2
- -1 nootropic Substances 0.000 description 2
- 230000001777 nootropic effect Effects 0.000 description 2
- 229940124549 vasodilator Drugs 0.000 description 2
- 239000003071 vasodilator agent Substances 0.000 description 2
- 235000013311 vegetables Nutrition 0.000 description 2
- 230000001755 vocal effect Effects 0.000 description 2
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- 206010007559 Cardiac failure congestive Diseases 0.000 description 1
- 235000008100 Ginkgo biloba Nutrition 0.000 description 1
- 244000194101 Ginkgo biloba Species 0.000 description 1
- 206010018367 Glomerulonephritis chronic Diseases 0.000 description 1
- 108010024636 Glutathione Proteins 0.000 description 1
- 206010019280 Heart failures Diseases 0.000 description 1
- 206010020850 Hyperthyroidism Diseases 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000002146 bilateral effect Effects 0.000 description 1
- 201000001352 cholecystitis Diseases 0.000 description 1
- 229910052804 chromium Inorganic materials 0.000 description 1
- GVJHHUAWPYXKBD-UHFFFAOYSA-N d-alpha-tocopherol Natural products OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 239000007941 film coated tablet Substances 0.000 description 1
- 229960003180 glutathione Drugs 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 230000002132 lysosomal effect Effects 0.000 description 1
- 229910052748 manganese Inorganic materials 0.000 description 1
- 238000012961 medicinal therapy Methods 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 230000000079 pharmacotherapeutic effect Effects 0.000 description 1
- 230000035935 pregnancy Effects 0.000 description 1
- 230000001172 regenerating effect Effects 0.000 description 1
- 229960003471 retinol Drugs 0.000 description 1
- 235000020944 retinol Nutrition 0.000 description 1
- 239000011607 retinol Substances 0.000 description 1
- 230000006641 stabilisation Effects 0.000 description 1
- 238000011105 stabilization Methods 0.000 description 1
- 230000017423 tissue regeneration Effects 0.000 description 1
- 229960001295 tocopherol Drugs 0.000 description 1
- 229930003799 tocopherol Natural products 0.000 description 1
- 235000010384 tocopherol Nutrition 0.000 description 1
- 239000011732 tocopherol Substances 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 description 1
Landscapes
- Nitrogen Condensed Heterocyclic Rings (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| MDA20130056A MD4277C1 (mo) | 2013-05-24 | 2013-05-24 | Utilizarea extractului din biomasa tulpinii cianobacteriei Spirulina platensis (Nordst) Getil CNMN-CB-02 pentru tratamentul pacienţilor cu hipoacuzie neurosenzorială |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| MDA20130056A MD4277C1 (mo) | 2013-05-24 | 2013-05-24 | Utilizarea extractului din biomasa tulpinii cianobacteriei Spirulina platensis (Nordst) Getil CNMN-CB-02 pentru tratamentul pacienţilor cu hipoacuzie neurosenzorială |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| MD4277B1 MD4277B1 (en) | 2014-03-31 |
| MD4277C1 true MD4277C1 (mo) | 2014-10-31 |
Family
ID=50685391
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MDA20130056A MD4277C1 (mo) | 2013-05-24 | 2013-05-24 | Utilizarea extractului din biomasa tulpinii cianobacteriei Spirulina platensis (Nordst) Getil CNMN-CB-02 pentru tratamentul pacienţilor cu hipoacuzie neurosenzorială |
Country Status (1)
| Country | Link |
|---|---|
| MD (1) | MD4277C1 (mo) |
-
2013
- 2013-05-24 MD MDA20130056A patent/MD4277C1/mo not_active IP Right Cessation
Non-Patent Citations (2)
| Title |
|---|
| Matcovschi C., Procopişin V., Parii B. Ghid farmacoterapeutic. Chişinău, Tipografia Centrală, 2006, p. 651-652 * |
| Французов Б. Л., Французова С. Б. Лекарственная терапия уха, горла и носа. Киев, 1988, р. 69 * |
Also Published As
| Publication number | Publication date |
|---|---|
| MD4277B1 (en) | 2014-03-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US12336974B2 (en) | Methods and compositions for preventing and treating auditory dysfunctions | |
| Oxana et al. | Mechanisms of phototherapy of Alzheimer’s disease during sleep and wakefulness: the role of the meningeal lymphatics | |
| Tassinari et al. | Ménière's disease treatment: a patient-centered systematic review | |
| Qu et al. | Inhalation of hydrogen gas attenuates ouabain-induced auditory neuropathy in gerbils | |
| Hinton et al. | Approaches to treat sensorineural hearing loss by hair-cell regeneration: The current state of therapeutic developments and their potential impact on audiological clinical practice | |
| EA201190109A1 (ru) | Изолированные популяции моноцитов и связанные с ними терапевтические применения | |
| KR101901412B1 (ko) | 적포도잎 추출물을 유효성분으로 함유하는 난청의 예방 또는 치료용 조성물 | |
| MD4277C1 (mo) | Utilizarea extractului din biomasa tulpinii cianobacteriei Spirulina platensis (Nordst) Getil CNMN-CB-02 pentru tratamentul pacienţilor cu hipoacuzie neurosenzorială | |
| JP2015529241A5 (mo) | ||
| Lin et al. | Protection of high-frequency low-intensity pulsed electric fields and brain-derived neurotrophic factor for SH-SY5Y cells against hydrogen peroxide-induced cell damage | |
| CN106474153A (zh) | 预防或治疗感音神经性耳聋或耳鸣的包括富含血小板的血浆的药物组合物及其使用方法 | |
| Ramachandran et al. | An in vitro study of electroporation of leukemia and cervical cancer cells | |
| KR20170002568A (ko) | 전혈로부터의 성체 줄기세포 증대 방법 | |
| Balatsouras et al. | The effect of MemoVigor 2 on recent-onset idiopathic tinnitus: a randomized double-blind placebo-controlled clinical trial | |
| RU2556500C1 (ru) | Способ лечения хронического гингивита, обусловленного табакокурением, у лиц молодого возраста в зависимости от свободно-радикального окисления ротовой жидкости | |
| RU2554813C1 (ru) | Способ лечения и профилактики нейросенсорной тугоухости и шумовых эффектов внутреннего уха, связанных с воздействием производственного шума | |
| Jang et al. | Effect of Ginkgo biloba extract on endotoxin-induced labyrinthitis | |
| Eyvazi et al. | A comparative study on photobiological effects of low-level laser therapy and tinnitus retraining therapy in patients with acoustic trauma-induced tinnitus | |
| Downs et al. | Etiology of neuroinflammatory pathologies in neurodegenerative diseases: A treatise | |
| RU2783255C1 (ru) | Способ лечения острой акустической травмы | |
| RU2392013C1 (ru) | Способ подавления приступа периферического системного головокружения с нарушением равновесия | |
| RU2428994C1 (ru) | Лейкотромбоцитарная масса и препарат на ее основе | |
| Talukder et al. | -Role of herbal products in curing Vitiligo | |
| Zabolotnyi et al. | HIRUDOTHERAPY IN PRESBYACUZIS PRAECOX IN CLEAN-UP WORKERS AFTER THE CHORNOBYL ACCIDENT DURING THE POST-CATASTROPHE YEARS. | |
| Bauer | L-Ergothioneine Treatment in Old CBA/CaJ Male Mice Slows the Progression of Age-related Hearing Loss |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG4A | Patent for invention issued | ||
| KA4A | Patent for invention lapsed due to non-payment of fees (with right of restoration) | ||
| MM4A | Patent for invention definitely lapsed due to non-payment of fees |